GlassScriptPhysician profile
John K Staheli
NPI 1275591620
$9,441.81
in general payments reported to CMS, 2019-2025
61 companies · $1,757 in 2025
The $1,757 reported for 2025 was more than what 85% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,283 · 2020: $396 · 2021: $891 · 2022: $1,431 · 2023: $1,778 · 2024: $1,905 · 2025: $1,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,148 · Education: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,147.62 |
| Education | $291.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,022.63 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $835.41 | 2019-2025 | |
| Lilly USA, LLC | $832.74 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $717.20 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Axsome Therapeutics, INC. | $680.71 | 2022-2025 | Sunosi |
| Astrazeneca Pharmaceuticals LP | $603.86 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Avadel Cns Pharmaceuticals, LLC | $470.94 | 2023-2025 | Lumryz |
| Novo Nordisk INC | $442.08 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $321.96 | 2019-2025 | Repatha, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $304.32 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $268.13 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.33 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Astellas Pharma US INC | $240.52 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $229.23 | 2022-2025 | |
| Pfizer INC. | $197.42 | 2019-2025 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $156.41 | 2019-2020 | |
| Philips North America LLC | $150.46 | 2019-2025 | Patient Interface Software |
| Sanofi Pasteur INC. | $149.37 | 2019-2025 | |
| Glaxosmithkline, LLC. | $124.54 | 2023-2025 | Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $122.62 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $112.68 | 2019-2022 | |
| Fisher & Paykel Healthcare INC | $89.29 | 2019-2025 | Fisher & Paykel Healthcare |
| Baxter Healthcare | $83.59 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Inspire Medical Systems, INC. | $77.67 | 2024-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $71.34 | 2019-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $71.31 | 2021-2025 | Verquvo, Belsomra, Steglatro |
| Avanir Pharmaceuticals, INC. | $57.31 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $45.12 | 2023-2024 | Quviviq |
| Resmed Corp | $44.23 | 2019-2022 | |
| Abbott Laboratories | $39.92 | 2020-2025 | Freestyle Libre 3 |
| Boston Scientific Corporation | $37.93 | 2022-2023 | Watchman Access System |
| Arbor Pharmaceuticals, INC. | $36.47 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $33.74 | 2023-2024 | Gemtesa |
| Radius Health, INC. | $32.73 | 2024 | Tymlos |
| Sunovion Pharmaceuticals INC. | $32.71 | 2022 | |
| 3b Medical, INC. | $32.48 | 2025 | Luna |
| Neurocrine Biosciences, INC. | $30.81 | 2024-2025 | Ingrezza |
| Edwards Lifesciences Corporation | $28.98 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Madrigal Pharmaceuticals | $25.94 | 2025 | Rezdiffra |
| Medtronic USA, INC. | $25.85 | 2019 | |
| Shire North American Group INC | $21.50 | 2019 | |
| Mylan Specialty L.P. | $21.00 | 2019 | |
| Dexcom, INC. | $19.47 | 2021 | |
| Biogen, INC. | $18.52 | 2021 | |
| Lundbeck LLC | $17.49 | 2023 | Rexulti |
| Aimmune Therapeutics, INC. | $17.29 | 2024 | |
| Mannkind Corporation | $16.84 | 2021 | |
| Ge Healthcare | $16.32 | 2019 | |
| Becton, Dickinson and Company | $15.81 | 2019 | |
| Averitas Pharma INC. | $14.71 | 2024 | Qutenza |
| Almatica Pharma LLC | $14.65 | 2023 | Loreev Xr |
| Kowa Pharmaceuticals America, INC. | $14.51 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.06 | 2024 | Caplyta |
| Phathom Pharmaceuticals, INC. | $14.01 | 2024 | Voquezna |
| Grifols USA, LLC | $13.56 | 2024 | Prolastin-C Liquid |
| Neurelis, INC. | $12.46 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.91 | 2021 | |
| Eisai INC. | $11.55 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.30 | 2021 | |
| Daiichi Sankyo INC. | $11.18 | 2019 | |
| Itamar Medical INC | $9.69 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Staheli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.